A Vision Leading to the Future of Neurohealth

Since our inception in 2003, Neuronetics has been focused on a vision of hope: the achievement of neurohealth for more people than ever before. Year after year, treatment after treatment, breakthrough by breakthrough, we’re proud to have remained true to this vision.

Today, we are inspiring more transformation and positive change than any treatment provider in our industry. Looking ahead, we look forward to renewing even more lives as we work to expand our capabilities to cover additional indications.

Image of a NeuroStar system in profile

“We are very excited about what the future holds at Neuronetics and look forward to leveraging the momentum we have built to continue to expand awareness and access to NeuroStar® Advanced Therapy for people who are suffering from depression.”

—Keith Sullivan, President & CEO

Timeline 1998 (Invention), 2003 (Neuronetics founded), 2004 (Begin design of NeuroStar System)
Timeline 2006 (Filed 510K with FDA), 2008 (FDA Clearance Awarded), 2009 (First Insurance Coverage)
Timeline 2010 (APA adds TMS to guidelines for MDD), 2011 (Neuronetics gains Technology Pioneer Award), 2012 (NeuroStar Products receive International CE Mark)
Timeline 2013 (Celebrating 10 years), 2014 (Long Term Durability Study Completed), 2016 (1 Million Treatments performed)
Timeline 2017 (FDA Clearamce for 19 Min Dash Protocol), 2018 (Neuronetics IPO), 2020 (Keith Sullivan appointed Neuronetics CEO)
Timeline 2021 Outcomes Registry Reaches 10K Patients Milestone

Looking Forward

For more information on what we do, how to join our team, or ways you can invest in our future, contact us today.

Contact Neuronetics